Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that lacks effective treatment options. Genervon has discovered and developed GM604 (GM6) as a potential ALS therapy. GM6 has been modeled upon an insulin receptor tyrosine kinase binding motoneuronotrophic factor within the developing central nervous system. https://www.nacrack.com/mega-choice-2005-2006-NISSAN-ALTIMA-Radio-Receiver-AM-FM-stereo-single-CD-Player-G-mega-value/